ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 118 filers reported holding ACCELERON PHARMA INC in Q1 2015. The put-call ratio across all filers is 0.99 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $243,000 | -56.5% | 0 | -100.0% | 1.87% | +7.8% |
| Q1 2017 | $559,000 | -5.9% | 21,106 | -9.3% | 1.73% | -17.6% |
| Q4 2016 | $594,000 | +75.7% | 23,272 | +148.9% | 2.10% | +149.1% |
| Q3 2016 | $338,000 | +6.3% | 9,351 | 0.0% | 0.84% | +34.0% |
| Q2 2016 | $318,000 | +28.7% | 9,351 | 0.0% | 0.63% | +33.8% |
| Q1 2016 | $247,000 | -45.8% | 9,351 | 0.0% | 0.47% | -37.9% |
| Q4 2015 | $456,000 | -27.3% | 9,351 | -62.9% | 0.76% | -38.6% |
| Q3 2015 | $627,000 | -21.3% | 25,194 | 0.0% | 1.24% | +22.4% |
| Q2 2015 | $797,000 | +23.2% | 25,194 | +48.2% | 1.01% | -16.7% |
| Q1 2015 | $647,000 | -23.2% | 16,996 | -21.3% | 1.21% | -41.9% |
| Q4 2014 | $842,000 | – | 21,603 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |